Rituximab for IgG4-related disease: a prospective, open-label trial.
Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH.
Carruthers MN, et al. Among authors: stone jh.
Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605. Epub 2015 Feb 9.
Ann Rheum Dis. 2015.
PMID: 25667206